Tailored ECMO treatment for cardiogenic shock
Part of Heart & circulation clinical trials.
This trial studies people who are starting ECMO, a machine that takes over the work of the heart and lungs, to see if a more tailored approach can improve outcomes. If you join, your care may be adjusted based on your specific needs.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 18 years old.
- You are about to start a treatment called VA ECMO (a machine that helps your heart and lungs work) because your heart is failing to pump enough blood or because you had a cardiac arrest.
- You are not already on ECMO right now.
- You will also be part of the EXCEL Registry, a related study that collects information about people on ECMO.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a device that helps support your heart when it's in cardiogenic shock (a life-threatening condition where the heart can't pump enough blood). The device works alongside standard treatments to improve blood flow and reduce strain on the heart.
This trial is studying whether using less of the medicines that raise blood pressure (vasopressors) can help people with severe heart failure who are on a heart-lung machine (ECMO) survive. It may answer if a gentler approach is safer.
This study tests whether adjusting the blood flow rate of an ECMO machine (which helps your heart pump) can improve blood flow to your organs and reduce stress on your heart during the critical early phase of cardiogenic shock. It aims to find the best ECMO settings to help you recover.
This trial tests if unloading the heart during ECMO support helps patients recover better from cardiogenic shock. It compares different ways to reduce the heart's workload.
This trial studies whether using a life-support machine called ECMO (extra support for the heart and lungs) helps people who develop shock right after a heart attack. It aims to improve outcomes when blood flow is failing and organs may be struggling.
This study will look at whether “left ventricular unloading” (using a device like IABP or Impella) helps people who are in cardiogenic shock while on VA ECMO. It compares outcomes for people who get unloading versus those who stay on VA ECMO alone.
Hear when a new Cardiogenic Shock trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.